FDA.reportPublic FDA data

10 ML hyaluronidase, human recombinant 160 UNT/ML Injection

RxCUI
1809535
RxNorm name
10 ML hyaluronidase, human recombinant 160 UNT/ML Injection
Display name
10 ML hyaluronidase, human recombinant 160 UNT/ML Injection
Full name
10 ML hyaluronidase, human recombinant 160 UNT/ML Injection
Term type
SCD
Status
DailyMed mapping
Updated
2026-06-04 23:39:05

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
125402HyqviaImmune Globulin Infusion (Human), 10% with Recombinant Human Hyaluronidase351(a)Rx2026-09-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
7ca2c26f-4be2-48cd-be5b-486e350654bahyaluronidase, human recombinant 1600 UNT in 10 ML Injection [PSN] · 10 ML hyaluronidase, human recombinant 160 UNT/ML Injection [SCD] · hyaluronidase, human recombinant 1600 UNT per 10 ML Injection [SY]322These highlights do not include all the information needed to use HYQVIA ® safely and effectively. See full prescribing information for HYQVIA. HYQVIA ® [Immune Globulin Infusion (Human), 10% with Recombinant Human Hyaluronidase] Solution, for subcutaneous administration Initial U.S. Approval: 201420260204